This page shows the latest Xyphos news and features for those working in and with pharma, biotech and healthcare.
Under the terms of the deal, Xyphos will be paid $120m upfront, with milestone payments worth up to $665m. ... In return, Astellas will gain Xyphos’ cell therapy technology platform and its expert research team.
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...